We generally tend to focus on different organs, but we forget that all the organs are internally connected. In this article, ...

The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...

EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...

NASH is now the number one cause of liver transplants for people under 50 in the US. As fat builds up in the liver, it triggers a cycle of chronic inflammation and fibrosis, which, left unchecked ...

Resmetirom is a medication approved by the FDA to treat adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with ...

NASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver, which can lead to fibrosis that impairs liver function. In a separate development ...

Popular liver supplements such as ... known as nonalcoholic steatohepatitis (NASH). A systematic review and meta-analysis of 15 human trials found that vitamin E supplementation improved liver enzymes ...

MASH (long known as NASH) is a more serious form of the disease. Liver damage associated with MASH can lead to fibrosis, cirrhosis, or hepatocellular carcinoma, the authors explained. One well ...